Down-regulation of beta-adrenergic and dopaminergic receptors induced by 2-phenylethylamine. (Q48278734)

10 February 2018

title

Down-regulation of beta-adrenergic and dopaminergic receptors induced by 2-phenylethylamine. (English)

1 reference

10 February 2018

1 reference

P R Paetsch

1

1 reference

10 February 2018

A J Greenshaw

series ordinal

2

1 reference

10 February 2018

publication date

1 June 1993

1 reference

10 February 2018

Cellular and Molecular Neurobiology

published in

1 reference

10 February 2018

volume

13

1 reference

10 February 2018

issue

3

1 reference

10 February 2018

page(s)

203-215

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/bf00733750

exact match

0 references

cites work

Beta-adrenoceptors and antidepressants: possible 2-phenylethylamine mediation of chronic phenelzine effects.

1 reference

12 December 2020

Phenylethylamine in paranoid chronic schizophrenia

1 reference

12 December 2020

Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands

1 reference

12 December 2020

Effects of chronic antidepressant treatment on dopamine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum

1 reference

12 December 2020

Quantitative assessment of central beta 1- and beta 2-adrenoceptor regulation using CGP 20712 A.

1 reference

12 December 2020

Formation of beta-phenylethylamine from the antidepressant, beta-phenylethylhydrazine

1 reference

12 December 2020

The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum

1 reference

12 December 2020

In vivo release of endogenous dopamine from rat caudate nucleus by phenylethylamine.

1 reference

12 December 2020

Osmotic mini-pumps: a convenient program for weight-adjusted filling concentrations

1 reference

12 December 2020

Enzymatic isotopic assay for and presence of beta-phenylethylamine in brain.

1 reference

12 December 2020

Regulation of aromatic L-amino acid decarboxylase by dopamine receptors in the rat brain

1 reference

12 December 2020

Phenylethylaminergic mechanisms in attention-deficit disorder

1 reference

12 December 2020

Phenylethylamine metabolism in Tourette's syndrome

1 reference

12 December 2020

Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes

1 reference

12 December 2020

Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system

1 reference

12 December 2020

Separation, detection and quantitative, analysis of urinary β-phenylethylamine

1 reference

12 December 2020

Effects of sodium, lithium, and magnesium on in vitro binding of [3H]SCH23390 in rat neostriatum and cerebral cortex

1 reference

12 December 2020

Effects of acute and chronic administration of phenelzine on 2-phenylethylamine levels in rat brain.

1 reference

12 December 2020

β 1 - and β 2 -Adrenergic Receptors in Rat Cerebral Cortex Are Independently Regulated

1 reference

12 December 2020

Aromatic L-amino acid decarboxylase is modulated by D1 dopamine receptors in rat retina

1 reference

12 December 2020

In vivo release of endogenous dopamine from rat caudate nucleus by beta-phenylethylamine and alpha,alpha,-dideutero-beta-phenylethylamine

1 reference

12 December 2020

Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment

1 reference

12 December 2020

Repeated treatment with antidepressant drugs prevents salbutamol-induced hypoactivity in rats

1 reference

12 December 2020

Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol

1 reference

12 December 2020

Antidepressant treatments, including sibutramine hydrochloride and electroconvulsive shock, decrease beta 1- but not beta 2-adrenoceptors in rat cortex

1 reference

12 December 2020

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

12 December 2020

Plasma phenylethylamine and phenylalanine in chronic schizophrenic patients

1 reference

12 December 2020

Effects of tranylcypromine on the concentration of some trace amines in the diencephalon and hippocampus of the rat

1 reference

12 December 2020

Kinetic measurements of the turnover rates of phenylethylamine and tryptamine in vivo in the rat brain.

1 reference

12 December 2020

The effect of chronic treatment with antidepressant drugs on salbutamol-induced hypoactivity in rats.

1 reference

12 December 2020

Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine

1 reference

12 December 2020

Independent regulation of beta 1- and beta 2-adrenoceptors

1 reference

12 December 2020

Phenylethylamine Hypothesis of Affective Behavior

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

2-Phenylethylamine: a modulator of catecholamine transmission in the mammalian central nervous system?

1 reference

12 December 2020

Release of monoamines from striatal slices by phenelzine and beta-phenylethylamine.

1 reference

12 December 2020

Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements

1 reference

12 December 2020

Steric requirements for catecholamine uptake by rat brain synaptosomes: studies with rigid analogs of amphetamine.

1 reference

12 December 2020

Increase in urinary beta-phenylethylamine preceding the switch from mania to depression: a "rapid cycler"

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00733750

1 reference

10 February 2018

PubMed ID

8242685

1 reference

10 February 2018